Presentation is loading. Please wait.

Presentation is loading. Please wait.

PANTIPA TONSAWAN, M.D. July 5, 2013

Similar presentations


Presentation on theme: "PANTIPA TONSAWAN, M.D. July 5, 2013"— Presentation transcript:

1 PANTIPA TONSAWAN, M.D. July 5, 2013
First few session care PANTIPA TONSAWAN, M.D. July 5, 2013

2 Scope  Relation : ESRD , HD & death  Pre HD patient evaluation
 HD prescription (initial treatment)  HD complication (Initial treatment)

3 Impact : ESRD,HD & death

4 Probability of sudden cardiac death in incident dialysis patients
Month after dialysis U.S. Renal Data System, USRDS 2012 Annual Data Report

5 Causes of death : prevalent dialysis patients, 2008–2010
ESRD pt Cardiac causes U.S. Renal Data System, USRDS 2012 Annual Data Report

6 Rates of sudden cardiac death : age
Period prevalent dialysis patients, age 20 & older, unadjusted. U.S. Renal Data System, USRDS 2012 Annual Data Report

7 U.S. Renal Data System, USRDS 2012 Annual Data Report
Rates of sudden cardiac death prevalent dialysis patients, by primary diagnosis Death /1000 patient years 2000 2005 2010 U.S. Renal Data System, USRDS 2012 Annual Data Report

8 U.S. Renal Data System, USRDS 2012 Annual Data Report
Rates of sudden cardiac death following initiation of treatment in incident HD patients 0-90 days : 1/10 Death /1000 patient years 2000 2006 2007 2007 2009 U.S. Renal Data System, USRDS 2012 Annual Data Report

9 Caution !!! : sudden cardiac death
 RRT : Hemodialysis  Aging : Exp > 65 yrs…>75 yrs  Underlying : DM, HT  Duration initial treatment : 0-90 days

10 Patient evaluation

11 Hemodialysis prescription
Pre HD Evaluation Vascular access Hemodialysis prescription Patient information

12 Patient information 1.History taking  Indication & complication
Acute or chronic HD, hyper K, volume↑  Underlying disease…DM, HT, IHD  Active problem ..GI Bleed, MI, stroke  Hemodynamic status  Arrhythmia, BP  Medication  Anti HT, anti coagulant

13 Patient information 2.Laboratory data
 CBC :  Hb/HCT, Platelet…..risk bleeding  BUN/Cr :  High BUN…..Risk ….DDS  Electrolyte :  Select : Dialysate solution component  Serology:  HBV, HCV, HIV…..isolated

14 Vascular access : initial use Arteriovenous fislula
Prepare : 3-6 mo ….. Maturation Prompt ? Arteriovenous graft Prepare : 3-6 wk : at least 2 wk after Surgery Infection ? HD catheter Exit site, redness, warm immediately use ..complication ?

15 Hemodialysis prescription

16 Order HD prescription (initial treatment)
 Session length : Perform HD 2 hrs  BFR : 200 ml/min  Dialyzer: Low flux  Dialysate solution composition: Na …, K…., HCO3 …, Ca…, Mg…, Dextrose…..  DFR : 500 ml/min  Dialysis solution temp. : 36oc  Fluid removal order: remove … Lite Anti-coagulant : heparinloading..,maintenance … (หรือnon-heparin ตามความเหมาะสม)  50 % glucose ml intra HD (พิจารณาตามความเหมาะสมของผู้ป่วยแต่ละราย) Daugirdas JT. Acute & Chronic hemodialysis prescription; Handbook of dialysis 2007

17 HD prescription (initial treatment)
 Time: initial 2 hr… ↑ 30 min q HD ……until 4 hr  BFR : initial ml/min …↑ 30 min q HD ……until ml/min  Dialyzer : initial low flux, low SA …. (AIM ….Kt/V , URR 40 %)  DFR : 500 ml/min …800ml/min (high BFR) Daugirdas JT. Acute & Chronic hemodialysis prescription; Handbook of dialysis 2007

18 HD prescription (initial treatment)
 Dialysate composition : Na K Ca HCO3 Acute 145 2, 3, 4 3.5 25 Chronic 2,3 2.5 32  Temp. : low temp prevent Hypotension 36.5 C  UF : < 1 L /hr, ….if need…sequential HD  Hypertonic solution : 50 % glucose ….DDS  Anticoagulant : depend on patient. condition Daugirdas JT. Acute & Chronic hemodialysis prescription; Handbook of dialysis 2007

19 Hemodialysis complications

20 Dialysis disequilibrium syndrome
Acute neurological complication Consequence of rapid HD …osmotic gradient brain Vs plasma caused .. cerebral edema Risk factor 1st session hemodialysis  Extreme age : child or aging  High BUN level: > 125 mg/dl  CNS disorder (stroke, tumor, dementia,hypo Na), head injury (subdural hematoma) …. Pediatr Nephrol (2012) 27:2205–2211 Seminars in Dialysis—Vol 20, No pp. 493–498

21 Dialysis disequilibrium syndrome
ICF ECF IVF I Urea CF : brain ICF : brain Brain Urea Urea H2O Urea↑ High Osm Urea H20 slow Reverse osmotic shift HD Cerebral edema

22 Dialysis disequilibrium syndrome
Clinical : fatigue, mild headache, nausea, vomiting, disturbed consciousness, convulsions… coma. Common mild..Self limited, fatal.. if severe Diagnosis Clinical diagnosis (during HD, after HD) + risk factor Exclusion other condition Treatment Symptomatic treatment/ hypertonic solution/ + stop HD Seminars in Dialysis—Vol 20, No pp. 493–498

23 Dialysis disequilibrium syndrome
Prevention Most important  Dialysis time (2 hours) Blood flow rate 200 ml/min  Less efficient (small) dialyzer  Hypertonic solution  A goal URR : 0.4–0.45 or diffusive Kt/V of 0.6–0.7 Seminars in Dialysis—Vol 20, No pp. 493–498

24 Cardiac arrhythmia, Ischemia, sudden death
 DIALYSIS-INDUCED MYOCARDIAL STUNNING Echocardiogram - Pre HD …normal - During HD …. RWMA abnormality - Post HD 30 min …normal Semin Dial 2007; 20: 220–228  Positron emission tomography : Measure ..MBF dialysis ….. HD precipitates reductions MBF CAG …..normal Clin J Am Soc Nephrol 2008; 3: 19–26. Effects of hemodialysis on cardiac function ;Kidney International (2009) 76, 371–375

25 Cardiac arrhythmia, Ischemia, sudden death
 DIALYSIS-INDUCED CARDIAC ISCHEMIA Myocardial stunning : Occur ….60 % Related to UF (total/rate ) & HD instability Long term High mortality PET Effects of hemodialysis on cardiac function ;Kidney International (2009) 76, 371–375

26 Intradialytic hypotension
Initial treatment : associated cause High UF rate : limit time Trial & error : set DW High dose : anti HT Nutrition status : malnutrition …low plasma refilling Treatment  Sequential HD  Limit IDWG < 1 kg/day  Decrease anti HT ….decrease DW  Avoid : eating during HD  low Temp.

27 Type A : anaphylactic type
Dialyzer reaction Type A : anaphylactic type Type B :non-specific  Full brown, Severe reaction  Common : 5 min after HD…but delayed 30 min  Cause : ETO oxide, AN 69 reaction, contaminated dialysis solution, reuse First use syndrome Management : Safest to stop dailysis, without returning blood  Cardiorespiratory support Prevention : proper rinsing, y-irradiated or stream-sterilized dialyzer

28 Dialyzer reaction  Supportive care
Type B :non-specific  Mild symptoms : chest pain, back pain  Onset min after HD  Cause : unknown Management :  Supportive care  Differential diagnosis : coronary artery disease

29 Post HD care Complication Next session HD

30 Summary  Cardiovascular : common cause of death HD patient  Risk : aging, DM, HT, HD 0-90 day  Pre HD patient evaluation: important …Recognized risk of HD complication  Appropriate HD prescription …reduce & prevent HD complication  Prompt to treatment of complication : if HD… started


Download ppt "PANTIPA TONSAWAN, M.D. July 5, 2013"

Similar presentations


Ads by Google